Pleconaril

This classification denotes an anti-infective agent with the molecular formula C18H18F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9H4570Q89D, chemically known as 1,2,4-oxadiazole, 3-(3,5-dimethyl-4-(3-(3-methyl-5-isoxazolyl)propoxy)phenyl)-5-(trifluoromethyl)- but generally known as pleconaril, which bears US NIH Compound Identifier 1684. European Medicines Agency schedules Pleconaril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09957MIG. The term PLECONARIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). World Health Organization schedules pleconaril in its Anatomical Therapeutic Chemical (ATC) Classification. PLECONARIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pleconaril under HS 29349990 and SITC 51579. As of Q4 2014, PLECONARIL remains the US FDA Preferred Term for this commodity. Pleconaril bears US NLM identifiers UMLS ID C0759032 and NCI Concept Code C81604. SMILES: FC(F)(F)c1onc(n1)c1cc(c(OCCCc2onc(c2)C)c(c1)C)C.